These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3474777)
41. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T; Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945 [TBL] [Abstract][Full Text] [Related]
42. [Long-term drug therapy of rheumatoid arthritis and remission]. Piaĭ L; Piaĭ S Ter Arkh; 2000; 72(5):21-5. PubMed ID: 11109613 [TBL] [Abstract][Full Text] [Related]
43. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL; Watson KD; Silman AJ; Symmons DP; Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046 [TBL] [Abstract][Full Text] [Related]
45. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW; Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899 [TBL] [Abstract][Full Text] [Related]
46. [A case of rheumatoid arthritis complicated with auranofin-induced acute interstitial pneumonitis]. Okuda Y; Takasugi K; Imai A; Hasimoto F; Kondo Y; Hatinota M; Ueda S; Nitta M Ryumachi; 1991 Feb; 31(1):54-61; discussion 59-60. PubMed ID: 1857997 [TBL] [Abstract][Full Text] [Related]
47. Incidence and management of diarrhea during longterm auranofin therapy. Wallin BA; McCafferty JP; Fox MJ; Cooper DR; Goldschmidt MS J Rheumatol; 1988 Dec; 15(12):1755-8. PubMed ID: 3265956 [TBL] [Abstract][Full Text] [Related]
48. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial. Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D J Rheumatol; 1991 Aug; 18(8):1240-2. PubMed ID: 1941832 [TBL] [Abstract][Full Text] [Related]
49. [The effect of Ridaura on cardiac function in patients with rheumatoid arthritis (based on echocardiographic data)]. Nemchinov EN; Chichasova NV; Kanevskaia MZ; Slobodina GA Revmatologiia (Mosk); 1990; (1):12-7. PubMed ID: 1974083 [TBL] [Abstract][Full Text] [Related]
50. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766 [TBL] [Abstract][Full Text] [Related]
51. The cost effectiveness of auranofin: results of a randomized clinical trial. Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585 [TBL] [Abstract][Full Text] [Related]
52. A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis. Rau R; Schattenkirchner M; Muller-Fassbender H; Kaik B; Zeidler H; Missler B Clin Rheumatol; 1990 Dec; 9(4):461-74. PubMed ID: 2128475 [TBL] [Abstract][Full Text] [Related]
53. [Frequency and prognostic features of rheumatoid patients with remission-inducing agents--a comparison of different kinds of medication]. Kutsuna T; Maeda K; Okamoto T; Kawaguchi M Ryumachi; 1990 Oct; 30(5):336-42. PubMed ID: 2084855 [TBL] [Abstract][Full Text] [Related]
55. Gynecomastia as a complication of auranofin therapy. Williams HJ J Rheumatol; 1988 Dec; 15(12):1863-4. PubMed ID: 3230571 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of auranofin in patients with active early rheumatoid arthritis. Itokazu M; Matsunaga T; Oshita Y Clin Ther; 1995; 17(1):60-73. PubMed ID: 7758062 [TBL] [Abstract][Full Text] [Related]
57. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis. Vischer TL Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924 [TBL] [Abstract][Full Text] [Related]
58. Effects of auranofin and other antirheumatic drugs on human myelopoiesis in vitro. Hamilton JA; Williams N J Rheumatol; 1987 Apr; 14(2):216-20. PubMed ID: 2885415 [TBL] [Abstract][Full Text] [Related]
59. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures. Morgan GJ Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681 [TBL] [Abstract][Full Text] [Related]
60. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Paulus HE; Egger MJ; Ward JR; Williams HJ Arthritis Rheum; 1990 Apr; 33(4):477-84. PubMed ID: 2109613 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]